| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2023 ( Subtotal = $999,578 ) |
| 2023 | 2023 | HILLHURST BIOPHARMACEUTICALS, INC. | 2029 N VERDUGO RD | GLENDALE | CA | 91208 | LOS ANGELES | USA | Blood Diseases and Resources Research | 000 | 5 | 3/13/2023 | COMPETING CONTINUATION | $999,578 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| 2021 | 2019 | HILLHURST BIOPHARMACEUTICALS, INC. | 2029 VERDUGO BLVD #125 | MONTROSE | CA | 91020 | LOS ANGELES | USA | Cardiovascular Diseases Research | 000 | 4 | 6/17/2021 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $702,410 ) |
| 2019 | 2019 | HILLHURST BIOPHARMACEUTICALS, INC. | 2029 VERDUGO BLVD #125 | MONTROSE | CA | 91020 | LOS ANGELES | USA | Cardiovascular Diseases Research | 001 | 4 | 7/23/2019 | NON-COMPETING CONTINUATION | $702,410 |
| 2019 | 2018 | HILLHURST BIOPHARMACEUTICALS, INC. | 2029 VERDUGO BLVD #125 | MONTROSE | CA | 91020 | LOS ANGELES | USA | Cardiovascular Diseases Research | 000 | 3 | 12/18/2018 | COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $1,270,298 ) |
| 2018 | 2018 | HILLHURST BIOPHARMACEUTICALS, INC. | 2029 VERDUGO BLVD #125 | MONTROSE | CA | 91020 | LOS ANGELES | USA | Cardiovascular Diseases Research | 000 | 3 | 9/20/2018 | COMPETING CONTINUATION | $1,270,298 |
|
|